Trial Profile
A Randomized Comparison of Twice-Daily Versus Once-Daily Asenapine for Schizophrenia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 May 2022
Price :
$35
*
At a glance
- Drugs Asenapine (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- 23 May 2014 According to ClinicalTrials.gov record, status changed from not yet recruiting to completed.
- 13 Mar 2012 New trial record